Paclitaxel and SN-38 Overcome Cisplatin Resistance of Ovarian Cancer Cell Lines by Down-regulating the Influx and Efflux System of Cisplatin
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2001.tb02146.x/fullpdf
Reference35 articles.
1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer;McGuire;N. Engl. J. Med.,1996
2. Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant HeLa cells;Minagawa;Jpn. J. Cancer Res.,1994
3. Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer;Masuda;Br. J. Cancer,1993
4. CPT-11 in combination with cisplatin for advanced non-small cell lung cancer;Masuda;J. Clin. Oncol.,1992
5. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/ CDDP);Ohmori;Jpn. J. Cancer Res.,1993
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas;Oncotarget;2024-02-22
2. A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer;Computers in Biology and Medicine;2023-02
3. Multi-technique physico-chemical characterization of particles generated by a gasoline engine: Towards measuring tailpipe emissions below 23 nm;Atmospheric Environment;2020-08
4. Identification of cisplatin sensitizers through high-throughput combinatorial screening;International Journal of Oncology;2018-06-19
5. Elucidation of the Molecular Interaction between Cisplatin and Flavonol(s) and their Effect on DNA Binding;Journal of Medicinal Chemistry;2013-02-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3